- Country: Ukraine
- Summary: Code Dk 021:2015: 33600000-6 Pharmaceutical Products (Voriconazole, Powder/Lyophilisate, 200 Mg Each; Glucose Solution for Infusions 5%, 200 Ml Each; Glucose Solution for Infusions 5%, 400 Ml Each; Erythropoietin Alfa...
- UAT Ref No: 133391108
- Deadline: 10 Jan 2026
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 11220000
- Notice Type: Tender
- Document Ref. No.: UA-2026-01-07-001845-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Code DK 021:2015: 33600000-6 Pharmaceutical products (Voriconazole, powder/lyophilisate, 200 mg each; Glucose solution for infusions 5%, 200 ml each; Glucose solution for infusions 5%, 400 ml each; Erythropoietin alfa, solution for injections, 2000 IU, 1 ml each, syringe; Theophylline solution for injection 20 mg/ml in 5 ml; Calcium gluconate solution for injection 100 mg/ml in 10 ml; Levofloxacin solution for infusions, 5 mg/ml, 100 ml; Bupivacaine, solution for spinal anesthesia, 5 mg/ml, 5 ml each; Bupivacaine, solution for injection, 5 mg/ml, 5 each ml; Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml each; Mannitol solution for infusions 150 mg/ml 200 ml; Sodium bicarbonate solution for infusions 40 mg/ml 200 ml; Sodium chloride, solution for infusions, 9 mg/ml 100 ml; Sodium chloride, solution for infusion, 9 mg/ml 200 ml; Sodium chloride, solution for infusions, 9 mg/ml 400 ml; Sodium chloride, solution for infusions, 9 mg/ml 1000 ml; Sodium chloride, solution for infusions, 9 mg/ml 3000 ml; Sodium chloride, solution for infusions, 9 mg/ml 500 ml; Enoxaparin sodium, solution for injection, 10,000 anti-Xa IU/ml, 5.0 ml each; Ofloxacin, solution for infusions, 2 mg/ml, 100 ml each; Piperacillin/tazobactam, powder (lyophilisate) for solution, 4 g/0.5 g each; Ringer's solution for infusions of 200 ml; Ringer's solution for infusions of 400 ml; Tranexamic acid solution for injections, 100 mg/ml in 5 ml; Ciprofloxacin solution for infusions, 2 mg/ml per 100 ml; Cefotaxime, powder for injections of 1 g; Ondansetron solution for injection 2 mg/ml in 2 ml; Ondansetron solution for injection 2 mg/ml... Type of purchase: goods Classifier and its relevant code: DC 021:2015: 33600000-6 — Pharmaceutical products 1. Term (term) of delivery (handover) of goods: until December 31, 2026. The supplier must be able to ensure the delivery of the goods within 10 working days after receiving the written order applications from the Customer in the manner specified by the S...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINCode Dk 021:2015: 33600000-6 Pharmaceutical Products (Voriconazole, Powder/Lyophilisate, 200 Mg Each; Glucose Solution for Infusions 5%, 200 Ml Each; Glucose Solution for Infusions 5%, 400 Ml Each; Erythropoietin Alfa... - Ukraine Tender
The PUBLIC NON-COMMERCIAL ENTERPRISE OF THE KHARKIV REGIONAL COUNCIL "REGIONAL MEDICAL CLINICAL CENTER OF UROLOGY AND NEPHROLOGY NAMED BY V.I. SHAPOVAL", a Government sector organization in Ukraine, has announced a new tender for Code Dk 021:2015: 33600000-6 Pharmaceutical Products (Voriconazole, Powder/Lyophilisate, 200 Mg Each; Glucose Solution for Infusions 5%, 200 Ml Each; Glucose Solution for Infusions 5%, 400 Ml Each; Erythropoietin Alfa.... This tender is published on UkraineTenders under UAT Ref No: 133391108 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2026-01-10.
The estimated tender value is UAH 11220000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
